Variant report
Variant | esv3328759 |
---|---|
Chromosome Location | chr6:86682093-86685399 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190974016 | chr6:86682098-86682099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs140187253 | chr6:86682113-86682114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183706465 | chr6:86682123-86682124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs116403533 | chr6:86682124-86682125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565287922 | chr6:86682153-86682154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs532863893 | chr6:86682185-86682186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548074417 | chr6:86682221-86682222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555962935 | chr6:86682238-86682239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566099736 | chr6:86682246-86682247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs56246009 | chr6:86682308-86682309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189146876 | chr6:86682340-86682341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192151519 | chr6:86682352-86682353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs142213083 | chr6:86682361-86682362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369018305 | chr6:86682429-86682430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183007497 | chr6:86682434-86682435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556333522 | chr6:86682435-86682436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146371586 | chr6:86682502-86682503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538570035 | chr6:86682514-86682515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553681553 | chr6:86682560-86682561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571996443 | chr6:86682583-86682584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575910935 | chr6:86682663-86682664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374289607 | chr6:86682679-86682680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534219777 | chr6:86682688-86682689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541758967 | chr6:86682700-86682701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554261469 | chr6:86682734-86682735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs576088538 | chr6:86682747-86682748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs543108525 | chr6:86682778-86682779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565488584 | chr6:86682811-86682812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs187962998 | chr6:86682834-86682835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs191795692 | chr6:86682858-86682859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139374165 | chr6:86682904-86682905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561739408 | chr6:86682916-86682917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530414851 | chr6:86682926-86682927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs80073810 | chr6:86682927-86682928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572453286 | chr6:86682934-86682935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs36011450 | chr6:86682966-86682967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531051936 | chr6:86682976-86682977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs184279735 | chr6:86682996-86682997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570592629 | chr6:86683022-86683023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10944169 | chr6:86683036-86683037 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs553544321 | chr6:86683123-86683124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376399131 | chr6:86683145-86683146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564560666 | chr6:86683146-86683147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539970324 | chr6:86683173-86683174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs78644215 | chr6:86683204-86683205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs117754107 | chr6:86683271-86683272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550367109 | chr6:86683282-86683283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554556707 | chr6:86683331-86683332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs145285839 | chr6:86683340-86683341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs34884820 | chr6:86683343-86683344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abnormal development | 18461090 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:86677800-86682800 | Enhancers | Ovary | ovary |
2 | chr6:86682800-86683400 | Weak transcription | Ovary | ovary |
3 | chr6:86683400-86683600 | Enhancers | Ovary | ovary |
4 | chr6:86685200-86686200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |